Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer, Stomach cancer
Closed
Phase 2
This study is looking at ibrutinib for people whose cancer cells have certain gene changes.
It is a study for people with:
cancer of the food pipe (oesophageal cancer)
cancer where the food pipe meets the stomach (gastro oesophageal junction cancer)
and the cancer has spread into nearby tissues or to another part of the body.
Recruitment start: 1 June 2016
Recruitment end: 16 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ian Chau
The Royal Marsden NHS Foundation Trust
Janssen Pharmaceuticals
Last reviewed: 6 October 2021
CRUK internal database number: 14977
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
